263 related articles for article (PubMed ID: 24903524)
1. Improved small molecule drug release from in situ forming poly(lactic-co-glycolic acid) scaffolds incorporating poly(β-amino ester) and hydroxyapatite microparticles.
Fisher PD; Palomino P; Milbrandt TA; Hilt JZ; Puleo DA
J Biomater Sci Polym Ed; 2014; 25(11):1174-93. PubMed ID: 24903524
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional poly(β-amino ester) hydrogel microparticles in periodontal in situ forming drug delivery systems.
Fisher PD; Clemens J; Zach Hilt J; Puleo DA
Biomed Mater; 2016 Mar; 11(2):025002. PubMed ID: 26947556
[TBL] [Abstract][Full Text] [Related]
3. Mechanical properties and dual drug delivery application of poly(lactic-co-glycolic acid) scaffolds fabricated with a poly(β-amino ester) porogen.
Clark A; Milbrandt TA; Hilt JZ; Puleo DA
Acta Biomater; 2014 May; 10(5):2125-32. PubMed ID: 24424269
[TBL] [Abstract][Full Text] [Related]
4. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
Desai KG; Mallery SR; Schwendeman SP
Eur J Pharm Biopharm; 2008 Sep; 70(1):187-98. PubMed ID: 18472254
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of osteoinduction by continual simvastatin release from poly(lactic-co-glycolic acid)-hydroxyapatite-simvastatin nano-fibrous scaffold.
Jiang L; Sun H; Yuan A; Zhang K; Li D; Li C; Shi C; Li X; Gao K; Zheng C; Yang B; Sun H
J Biomed Nanotechnol; 2013 Nov; 9(11):1921-8. PubMed ID: 24059091
[TBL] [Abstract][Full Text] [Related]
6. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable polymerized simvastatin stimulates bone formation.
Venkatesan N; Liyanage ADT; Castro-Núñez J; Asafo-Adjei T; Cunningham LL; Dziubla TD; Puleo DA
Acta Biomater; 2019 Jul; 93():192-199. PubMed ID: 31055123
[TBL] [Abstract][Full Text] [Related]
8. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
[TBL] [Abstract][Full Text] [Related]
9. Biocompatibility and bone-repairing effects: comparison between porous poly-lactic-co-glycolic acid and nano-hydroxyapatite/poly(lactic acid) scaffolds.
Zong C; Qian X; Tang Z; Hu Q; Chen J; Gao C; Tang R; Tong X; Wang J
J Biomed Nanotechnol; 2014 Jun; 10(6):1091-104. PubMed ID: 24749403
[TBL] [Abstract][Full Text] [Related]
10. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
11. In-situ forming PLGA implants: Towards less toxic solvents.
Ramos F; Willart JF; Neut C; Agossa K; Siepmann J; Siepmann F
Int J Pharm; 2024 May; 657():124121. PubMed ID: 38621617
[TBL] [Abstract][Full Text] [Related]
12. Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol.
Yoncheva K; Lambov N; Miloshev S
Drug Dev Ind Pharm; 2009 Apr; 35(4):449-54. PubMed ID: 19288298
[TBL] [Abstract][Full Text] [Related]
13. Poly(alpha-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology.
Zhang R; Ma PX
J Biomed Mater Res; 1999 Mar; 44(4):446-55. PubMed ID: 10397949
[TBL] [Abstract][Full Text] [Related]
14. Prolonged release from PLGA/HAp scaffolds containing drug-loaded PLGA/gelatin composite microspheres.
Tang G; Zhang H; Zhao Y; Li X; Yuan X; Wang M
J Mater Sci Mater Med; 2012 Feb; 23(2):419-29. PubMed ID: 22095448
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of chitosan/polyvinylpyrrolidone hydrogel scaffolds containing PLGA microparticles loaded with dexamethasone for biomedical applications.
Saeedi Garakani S; Davachi SM; Bagher Z; Heraji Esfahani A; Jenabi N; Atoufi Z; Khanmohammadi M; Abbaspourrad A; Rashedi H; Jalessi M
Int J Biol Macromol; 2020 Dec; 164():356-370. PubMed ID: 32682976
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
[TBL] [Abstract][Full Text] [Related]
17. Delivery of doxorubicin and paclitaxel from double-layered microparticles: The effects of layer thickness and dual-drug vs. single-drug loading.
Lee WL; Guo WM; Ho VHB; Saha A; Chong HC; Tan NS; Tan EY; Loo SCJ
Acta Biomater; 2015 Nov; 27():53-65. PubMed ID: 26340886
[TBL] [Abstract][Full Text] [Related]
18. 5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy.
Lin Y; Li Y; Ooi CP
J Mater Sci Mater Med; 2012 Oct; 23(10):2453-60. PubMed ID: 22843166
[TBL] [Abstract][Full Text] [Related]
19. Release of simvastatin from scaffolds of poly(lactic-co-glycolic) acid and biphasic ceramic designed for bone tissue regeneration.
Encarnação IC; Sordi MB; Aragones Á; Müller CMO; Moreira AC; Fernandes CP; Ramos JV; Cordeiro MMR; Fredel MC; Magini RS
J Biomed Mater Res B Appl Biomater; 2019 Aug; 107(6):2152-2164. PubMed ID: 30653823
[TBL] [Abstract][Full Text] [Related]
20. Effect of implant formation on drug release kinetics of in situ forming implants.
Suh MS; Kastellorizios M; Tipnis N; Zou Y; Wang Y; Choi S; Burgess DJ
Int J Pharm; 2021 Jan; 592():120105. PubMed ID: 33232755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
